Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Santa Rosa CA, Hartford CT, Washington D.C. DC,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase1, Recruiting
Active & Responsive
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT05723107
Phase1, Recruiting
Active & Responsive
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
for
Pancreatic Neoplasms
Location: Norwalk CT
Sponsor: Nuvance Health
Sex: All
Age: 50 - 70+
Code: NCT03250078
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Active & Responsive
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Location: Newport Beach CA, Denver CO, Dallas TX, Milwaukee WI
Sponsor: Aadi Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT05997056
Phase2, Recruiting
Active & Responsive
Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)
for
Cystic Fibrosis
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 16+
Code: NCT04002882
Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Chicago IL, Boston MA, Hackensack NJ, Buffalo NY, Portland OR,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase1, Phase2, Recruiting
Active & Responsive
A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer
Location: Westbury NY, Memphis TN
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06624059
Phase3, Recruiting
Active & Responsive
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
for
Lung Cancer, Non-Small Cell Lung Cancer
Location: Fullerton CA, Peoria IL, The Bronx NY, Cincinnati OH